SBIO

Investor Moves

Name	Value	Action	Change	Price	Current Price
Ken GriffinCitadel Advisors $925k17.7k shares AddQ1 2026 $466k $52.34 $54.21
Ken GriffinCitadel Advisors $-712.8K ExitQ3 2025 $713k -- $54.21
Ken GriffinCitadel Advisors $-712.8K ExitQ3 2025 $713k -- $54.21
Ken GriffinCitadel Advisors $-382.9K ExitQ3 2024 $383k -- $54.21
Ken GriffinCitadel Advisors $-382.9K ExitQ3 2024 $383k -- $54.21

News

prnewswire.comCREATOR TV SPORTS™ UNVEILS CREATOR LINEUP FOR INAUGURAL "CREATOR PICKLEBALL TOUR" AT VIDCON ANAHEIMprnewswire.comJun 15

etftrends.comHealthcare ETFs: From Broad Exposure to Big Breakthroughsetftrends.comJun 11

seekingalpha.comSabio Holdings Inc. (SBIO:CA) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 26

prnewswire.comCreator TV Sports™' Creator Poker Championship to Premiere on CBS Sports Networkprnewswire.comMay 12

seekingalpha.comSabio Holdings Inc. (SBIO:CA) Q4 2025 Earnings Call Transcriptseekingalpha.comMay 1

Trade SBIO

About ALPS Medical Breakthroughs ETF

The ALPS Medical Breakthroughs ETF (SBIO) is designed to largely mirror the investment returns of its reference benchmark, the S-Network Medical Breakthroughs Index (PMBI). This objective is pursued before accounting for any associated fees and operational costs.

IPO Date: Dec 31, 2014

Market Data

Open: $56.14
High: $56.14
Low: $54.75
Volume: 13.3K
Avg Volume: 30.4K
52W High: $57.77
52W Low: $29.33

Valuation

Market Cap: $160M
Dividend Yield: 1.17%

Financials

Financial statement snapshot is not available yet.

Events

DividendDec 19

$1.17346